
|Articles|October 9, 2003
New technology can detect low-level PSA following prostatectomy
Scientists at Northwestern University have developed an ultra-sensitivetechnology based on gold nanoparticles and DNA that can detect PSA whenpresent at extremely low levels in the blood sample. The new protein-detectionmethod could be used to monitor prostate cancer patients following surgery,according to the researchers, whose findings are published in the Sept.26 issue of the journal Science (2003; 301:1884-6).
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
ORIC-944 shows promise in combination with ARPIs for mCRPC
2
Radioligands and ADT alternatives emerge in prostate cancer treatment
3
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
4
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
5



















